Jefferies Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.8M Buy
239,779
+131,449
+121% +$45M 0.57% 23
2026
Q1
$38.1M Buy
108,330
+3,893
+4% +$1.39M 0.26% 65
2025
Q4
$34.2M Sell
104,437
-60,530
-37% -$19.2M 0.17% 106
2025
Q3
$46.6M Buy
164,967
+32,832
+25% +$9.52M 0.22% 65
2025
Q2
$36.9M Buy
132,135
+36,075
+38% +$10.2M 0.31% 66
2025
Q1
$29.9M Sell
96,060
-42,421
-31% -$12.5M 0.26% 55
2024
Q4
$36.1M Sell
138,481
-266,142
-66% -$79M 0.22% 82
2024
Q3
$130M Buy
404,623
+324,197
+403% +$106M 0.93% 15
2024
Q2
$25.1M Sell
80,426
-3,080
-4% -$905K 0.27% 59
2024
Q1
$23.7M Sell
83,506
-92,233
-52% -$27M 0.22% 71
2023
Q4
$50.6M Buy
175,739
+150,314
+591% +$41M 0.33% 45
2023
Q3
$6.83M Sell
25,425
-10,624
-29% -$2.65M 0.06% 262
2023
Q2
$8M Buy
36,049
+22,847
+173% +$5.3M 0.07% 253
2023
Q1
$3.19M Sell
13,202
-133,757
-91% -$32.8M 0.03% 509
2022
Q4
$38.6M Buy
+146,959
New +$39.4M 0.27% 55

Other funds holding AMGN

Jefferies Financial Group's AMGN Position: Q2 2026 in Review

Jefferies Financial Group increased its Amgen (AMGN) stake by 121% in Q2 2026, buying an estimated $45M and bringing the position to 239,779 shares worth $86.8M. The position accounts for 0.57% of the portfolio, ranked #23.

Jefferies Financial Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $130M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Jefferies Financial Group held 239,779 shares of Amgen worth $86.8M as of Q2 2026.
  • Jefferies Financial Group bought 131,449 Amgen shares in Q2 2026, an estimated $45M.
  • Amgen made up 0.57% of Jefferies Financial Group's portfolio in Q2 2026, its #23 holding.
  • Jefferies Financial Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's Amgen position peaked at $130M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.